Funding innovative projects to improve ovarian cancer research
Official title: Developmental Research Program
Funded at University of Tx Md Anderson Can Ctr · NIH-10931381 · Data updated 2026-11-12
This study is all about bringing together researchers from different fields to come up with new ideas and treatments for ovarian cancer, so we can better understand and help patients facing this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 19, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $81,388 |
| NIH project number | 5P50CA281701-02 |
| Project ID | NIH-10931381 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with ovarian cancer or those at high risk for developing the disease.
✕Less likely to help
Patients with cancers unrelated to ovarian cancer may not receive direct benefits from this research.
What this research studies
The Developmental Research Program (DRP) aims to support innovative projects that focus on ovarian cancer, even if the investigators' current work is not exclusively in this area. By providing financial support and fostering collaboration among researchers, the program encourages the development of new translational studies that can lead to significant advancements in understanding and treating ovarian cancer. This initiative allows for multi-institutional research projects that utilize expertise and resources from various disciplines, ultimately aiming to translate basic research into clinical applications for patients.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking advancements in the diagnosis and treatment of ovarian cancer.
How similar studies have gone: Previous research initiatives have shown success in fostering innovative approaches to cancer treatment through collaborative funding programs.
Where this research is happening
-
University of Tx Md Anderson Can Ctr
Houston, United States Active
Researchers
- Principal investigator: Bast, Robert C — University of Tx Md Anderson Can Ctr
- Study coordinator: Bast, Robert C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.